Abbott Laboratories Overview
Latest P/E ratio for Abbott Laboratories: 34.83 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow34.83
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Abbott Laboratories (ABT) currently reports a P/E ratio of 34.83. That is above the Healthcare sector average of 25.75. Use the charts on this page to explore Abbott Laboratories's P/E ratio history and peer comparisons.
Abbott Laboratories's P/E ratio of 34.83 is higher than the Healthcare sector average of 25.75. That is roughly 35.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Abbott Laboratories's market price to a fundamental measure such as earnings, sales, or book value. At 34.83, ABT can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 34.83, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.75. From there, open related valuation or income-statement pages for Abbott Laboratories, and consider following ABT for alerts when major investors trade the stock.
Abbott Laboratories is classified in the Healthcare sector. On P/E ratio, it currently shows 34.83 versus a sector average near 25.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ABT with unrelated industries.
